Valuation: Alcon Inc.

Market Cap 30.8B 27.37B 25.54B 23.28B 43.91B 2,961B 44.32B 309B 120B 1,514B 116B 113B 4,858B P/E 2026 *
37x
P/E 2027 * 22.7x
Enterprise Value 33.38B 29.66B 27.68B 25.23B 47.58B 3,209B 48.02B 335B 130B 1,640B 125B 123B 5,264B EV / Sales 2026 *
3.01x
EV / Sales 2027 * 2.74x
Free-Float
97.34%
Yield 2026 *
0.58%
Yield 2027 * 0.65%
1 day-0.66%
3 months+3.07%
1 week 57.04
Extreme 57.04
57.8
1 month 57.04
Extreme 57.04
57.8
Current year 48.16
Extreme 48.16
57.92
1 year 48.16
Extreme 48.16
57.92
3 years 48.16
Extreme 48.16
57.92
5 years 48.16
Extreme 48.16
57.92
10 years 48.16
Extreme 48.16
57.92
Manager TitleAgeSince
Chief Executive Officer 60 2018-06-30
Director of Finance/CFO 58 2019-04-07
Chief Tech/Sci/R&D Officer - 2024-12-31
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 2018-06-30
Director/Board Member 63 2019-01-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%-.--% - - 30.8B
+0.84%-3.74%-27.56%+1.79% 169B
-0.07%-2.55%-11.59%+12.86% 110B
+0.90%+1.13%-25.66%+3.60% 106B
-1.24%-0.76%-49.50%-12.08% 73.87B
-0.24%+0.69%+2.08%+71.44% 58.98B
-0.86%+2.96%+12.91%+61.58% 51.28B
-0.71%-3.82%-8.68%-31.71% 48.16B
+0.12%-0.17%-17.87%+21.91% 40.84B
-1.01%-1.45%+27.31%-6.14% 32.21B
Average -0.29%-0.86%-10.95%+13.69% 76.69B
Weighted average by Cap. -0.00%-1.30%-17.07%+11.23%

Financials

2026 *2027 *
Net sales 11.09B 9.85B 9.19B 8.38B 15.8B 1,066B 15.95B 111B 43.11B 545B 41.63B 40.72B 1,749B 11.77B 10.46B 9.76B 8.9B 16.78B 1,131B 16.93B 118B 45.77B 578B 44.19B 43.23B 1,856B
Net income 793M 704M 657M 599M 1.13B 76.19B 1.14B 7.95B 3.08B 38.95B 2.98B 2.91B 125B 1.33B 1.18B 1.1B 1.01B 1.9B 128B 1.92B 13.37B 5.18B 65.48B 5B 4.89B 210B
Net Debt 2.57B 2.29B 2.14B 1.95B 3.67B 248B 3.7B 25.84B 10.01B 127B 9.67B 9.46B 406B 1.48B 1.32B 1.23B 1.12B 2.12B 143B 2.14B 14.9B 5.77B 72.96B 5.57B 5.45B 234B
Logo Alcon Inc.
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
25,000
Date Price Change Volume
26-10-02 CHF 57.12 -.--% 0
26-10-01 CHF 57.12 -.--% 0
26-09-30 CHF 57.12 -.--% 0
26-09-29 CHF 57.12 -.--% 0
26-09-28 CHF 57.12 -.--% 0
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
63.72USD
Average target price
91.32USD
Spread / Average Target
+43.31%

Quarterly revenue - Rate of surprise